Nuveen Asset Management’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.15M | Hold |
392,443
| – | – | ﹤0.01% | 2658 |
|
|
2024
Q3 | $1.52M | Hold |
392,443
| – | – | ﹤0.01% | 2560 |
|
|
2024
Q2 | $2.02M | Buy |
392,443
+242,070
| +161% | +$1.24M | ﹤0.01% | 2394 |
|
|
2024
Q1 | $1.05M | Buy |
150,373
+42,280
| +39% | +$296K | ﹤0.01% | 2684 |
|
|
2023
Q4 | $958K | Buy |
108,093
+1,171
| +1% | +$10.4K | ﹤0.01% | 2748 |
|
|
2023
Q3 | $1.02M | Sell |
106,922
-16,273
| -13% | -$155K | ﹤0.01% | 2564 |
|
|
2023
Q2 | $1.8M | Buy |
123,195
+109,067
| +772% | +$1.6M | ﹤0.01% | 2391 |
|
|
2023
Q1 | $174K | Hold |
14,128
| – | – | ﹤0.01% | 3007 |
|
|
2022
Q4 | $262K | Buy |
+14,128
| New | +$262K | ﹤0.01% | 3015 |
|